Dashboard
Manage Tickers

INMD


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inmode-defends-its-feminine-rejuvenation-patent-against-btl-industries-review-request
InMode Defends Its Feminine Rejuvenation P...
04/15/2024 11:08:08

InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to th...

barclays-maintains-overweight-on-inmode-lowers-price-target-to-33
Barclays Maintains Overweight on InMode, L...
04/12/2024 13:59:14

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $34 to $33.

btl-petitions-uspto-to-cancel-all-58-claims-of-us-patent-no-8961511-owned-by-the-company-inmode-ltd
BTL Petitions USPTO To Cancel All 58 Claim...
04/11/2024 13:27:53

BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel...

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
04/09/2024 15:53:24

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

maxeon-solar-technologies-neogen-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Maxeon Solar Technologies, Neogen And Othe...
04/09/2024 11:42:21

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar...

Core News & Articles
CORRECTION: OneMedNet Ticker Is 'ONMD'
04/03/2024 11:15:29

a-look-into-healthcare-sector-value-stocks
A Look Into Healthcare Sector Value Stocks
03/11/2024 14:43:58

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
02/26/2024 14:44:21

why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Fluor Shares Are Trading Lower By Arou...
02/20/2024 18:21:11

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

inmode-expects-fy24-revenue-of-495m-505m-vs-49928m-est-adj-eps-of-253-257-vs-245-est
InMode Expects FY24 Revenue Of $495M-$505M...
02/13/2024 12:07:01

inmode-q4-adj-eps-071-beats-067-estimate-sales-12678m-beat-12504m-estimate
InMode Q4 Adj. EPS $0.71 Beats $0.67 Estim...
02/13/2024 12:02:59

InMode (NASDAQ:INMD) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.67 by 5.97 ...

earnings-scheduled-for-february-13-2024
Earnings Scheduled For February 13, 2024
02/13/2024 10:05:59

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

inmodes-earnings-a-preview
InMode's Earnings: A Preview
02/12/2024 16:01:26

barclays-maintains-overweight-on-inmode-lowers-price-target-to-32
Barclays Maintains Overweight on InMode, L...
01/18/2024 14:10:55

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $33 to $32.

barclays-maintains-overweight-on-inmode-lowers-price-target-to-33
Barclays Maintains Overweight on InMode, L...
01/04/2024 13:06:11

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $45 to $33.

canaccord-genuity-reiterates-hold-on-inmode-maintains-22-price-target
Canaccord Genuity Reiterates Hold on InMod...
12/07/2023 15:48:01

Canaccord Genuity analyst Caitlin Cronin reiterates InMode (NASDAQ:INMD) with a Hold and maintains $22 price target.

israel-based-medical-technology-company-inmode-trims-fy23-outlook-again-stock-tanks
Israel-Based Medical Technology Company In...
12/06/2023 13:39:45

InMode Ltd (NASDAQ: INMD) shares are trading lower by around 13% after it 

inmode-cuts-2023-revenue-outlook-from-500m-510m-to-485m-495m-adj-eps-from-253-257-to-247-250
InMode Cuts 2023 Revenue Outlook From $500...
12/06/2023 12:09:08

inmode-revises-full-year-2023-guidance-citing-slowdown-in-platform-sales-mainly-in-north-america
InMode Revises Full-Year 2023 Guidance Cit...
12/06/2023 12:07:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION